New Technologies in Oral Reconstructive Medicine
AAP/SEPA/Osteology Consensus Workshop



Why this consensus matters
Oral reconstructive medicine is entering a new phase. Advances in scaffolds, biologics, cell therapies, digital workflows, and artificial intelligence are reshaping how clinicians approach hard- and soft-tissue regeneration around teeth and dental implants.
Jointly organized by the AAP, SEPA, and the Osteology Foundation in 2025, this consensus workshop brought together international experts to review current evidence on new technologies in oral reconstructive medicine.
They explored what is already supported, what remains emerging, and how these technologies may improve patient outcomes, reduce morbidity, and enable more personalized regenerative care.
Quick facts
about the meeting
42 experts from North America, Europe, and Australia collaborated to define the future of oral reconstructive medicine.
A unique collaboration between the Osteology Foundation, the AAP (American Academy of Periodontology), and the Sepa (Spanish Society of Periodontology).
The consensus was informed by 5 commissioned systematic reviews, providing a robust scientific basis for every recommendation.
One of the first international consensus reports to explicitly discuss the role of artificial intelligence and personalized medicine in regenerative therapies.
5 articles not to miss
Explore the systematic reviews that informed the consensus.
Hover over each card to access the full articles on the Journal of Periodontology.

We found promising bone gains with this approach. Complications remain an important consideration, and surgical experience is key to successful outcomes.
Read the full article
Autogenous grafts remain the most predictable, but selected substitutes can achieve comparable outcomes in specific indications - while substantially reducing patient morbidity.
Read the full article
Biologically – potentially yes, but not necessarily dimensionally in every indication. While evidence was weaker for some indications, the clearest clinical benefit was seen in ridge augmentation and preservation.
Read the full article
Alone or as adjuncts to autogenous grafts, these approaches show promise for augmenting keratinized mucosa and soft tissue thickness around dental implants. Further evidence is needed to redefine the standard of care.
Read the full article

Soft tissue substitutes already offer effective alternatives to autogenous tissue harvesting, while emerging bone regeneration technologies show promise that requires long-term clinical validation.
Read the full articleRead the consensus report
Building on the findings of the five systematic reviews and discussions during the in-person meeting of international experts, the consensus report summarizes current opportunities, limitations and future directions for the clinical application of emerging technologies in oral reconstructive medicine.

Read the papers
